Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Short term Debt (2021 - 2024)

LifeStance Health (LFST) has disclosed Short term Debt for 4 consecutive years, with $2.5 million as the latest value for Q3 2024.

  • On a quarterly basis, Short term Debt fell 72.11% to $2.5 million in Q3 2024 year-over-year; TTM through Sep 2024 was $2.5 million, a 72.11% decrease, with the full-year FY2023 number at $8.2 million, down 48.54% from a year prior.
  • Short term Debt was $2.5 million for Q3 2024 at LifeStance Health, down from $3.8 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $15.9 million in Q4 2022 to a low of $2.5 million in Q3 2024.
  • A 4-year average of $10.0 million and a median of $10.7 million in 2022 define the central range for Short term Debt.
  • Peak YoY movement for Short term Debt: rose 17.29% in 2023, then plummeted 72.11% in 2024.
  • LifeStance Health's Short term Debt stood at $14.1 million in 2021, then increased by 12.41% to $15.9 million in 2022, then plummeted by 48.54% to $8.2 million in 2023, then crashed by 69.4% to $2.5 million in 2024.
  • Per Business Quant, the three most recent readings for LFST's Short term Debt are $2.5 million (Q3 2024), $3.8 million (Q2 2024), and $4.5 million (Q1 2024).